Soluble ST2 in end‐stage heart failure, before and after support with a left ventricular assist device

BACKGROUND: The interleukin‐33 (IL‐33)/suppressor of tumorigenicity 2 (ST2) pathway is suggested to play an important role in fibrosis, remodelling and the progression of heart failure (HF). Increased soluble (sST2) levels are associated with adverse outcome in the average HF population. Less is kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Cheyenne C. S., Huibers, Manon M. H., Gaykema, Lonneke H., Siera‐de Koning, Erica, Ramjankhan, Faiz Z., Maisel, Alan S., de Jonge, Nicolaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838535/
https://www.ncbi.nlm.nih.gov/pubmed/29325227
http://dx.doi.org/10.1111/eci.12886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838535/
https://www.ncbi.nlm.nih.gov/pubmed/29325227
http://dx.doi.org/10.1111/eci.12886

Ejemplares similares